PRKN and neoplasm: Besides, it has been discovered that a depletion of PARK2 promotes the progression of esophageal squamous cell carcinoma (ESCC) via the Hippo/YAP axis, whereas overexpression of PARK2 suppresses tumor progression of ESCC through the Hippo signaling pathway.